1 of 1
Click on image to open expanded view
Item No.
50636
Calvenza-03 EIV/EHV Description
Calvenza-03 EIV/EHV is for the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease caused by equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4), and for equine influenza types A2 North American and A2 Eurasian strains. Available in 2 ml single dose syringe and 20 ml 10 dose vial.
*This item can't be shipped to MN.
What is Calvenza-03 EIV/EHV?
For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease caused by equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4), and for equine influenza types A2 North American and A2 Eurasian strains.
Which animals/pets is Calvenza-03 EIV/EHV for?
Horses (6 months of age or older)
Calvenza-03 EIV/EHV uses
-Protects your horse against A2 North American and A2 Eurasian influenza + helps protect horses from getting rhinopneumonitis respiratory disease caused by EHV-4 and EHV-1.
-Proven safe
-Minimal vaccine site reactions
What does Calvenza-03 EIV/EHV do?
Killed rhinopneumonitis virus helps protect healthy horses from getting rhinopneumonitis respiratory disease caused by EHV-4 and EHV-1, plus killed inluenza virus helps protect your horse against respiratory disease caused by equine influenza types A2 North American and A2 Eurasian strains.
Calvenza-03 EIV/EHV side effects
Anaphylactoid reactions may occur following use. In some instances, transient local reactions may occur at the injection site.
Calvenza-03 EIV/EHV ingredients
Killed Equine Rhinopneumonitis-Influenza Virus
Calvenza-03 EIV/EHV overdose: What to do?
Contact your nearest emergency animal hospital
What to know before using Calvenza-03 EIV/EHV
Keep away from children. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.
How is Calvenza-03 EIV/EHV sold?
Available in 2 ml single dose syringe and 20 ml 10 dose vial.
Manufacturer
Boehringer Ingelheim
Overview
Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 2 ml dose. Administer a second 2 ml dose intramuscularly in 3-4 weeks using a different injection site. Administer a third 2 ml dose in 3-4 weeks by either the intramuscular or intranasal route. Revaccinate annually and prior to anticipated exposure, by either the intramuscular or intranasal route.
Main Ingredients
Killed Equine Rhinopneumonitis-Influenza Virus